StonvexLoading…
StonvexStonvexStonvexCore line items from RVMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $11.58M | $35.38M |
Operating Income | $-1.18B | $-689.52M | $-487.19M | $-258.28M |
Net Income | $-1.13B | $-600.09M | $-436.37M | $-248.71M |
EPS (Diluted) | $-5.95 | $-3.58 | $-3.86 | $-3.08 |
Total Assets | $2.35B | $2.56B | $2.06B | $811.93M |
Total Liabilities | $723.21M | $293.10M | $235.51M | $126.74M |
Cash & Equivalents | $383.75M | $543.06M | $696.15M | $161.41M |
Free Cash Flow OCF − CapEx | $-913.73M | $-567.74M | $-358.30M | $-235.22M |
Shares Outstanding | 197.00M | 185.90M | 164.67M | 90.41M |